Daily Archives: February 21, 2020

Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis

Posted on February 21, 2020 by Gastroenterology Journal

We evaluated the efficacy and safety of upadacitinib, an oral selective inhibitor of Janus kinase 1, as induction therapy for ulcerative colitis (UC). Continue reading →

Posted in News | Comments Off on Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis

IW-3718 Reduces Heartburn Severity in Patients With Refractory Gastroesophageal Reflux Disease in a Randomized Trial

Posted on February 21, 2020 by Gastroenterology Journal

Refractory gastroesophageal reflux disease (GERD) reduces quality of life and creates significant financial burden on the healthcare system. Approximately 30% of patients with GERD who receive label-dose proton pump inhibitors (PPIs) still have symptom… Continue reading →

Posted in News | Comments Off on IW-3718 Reduces Heartburn Severity in Patients With Refractory Gastroesophageal Reflux Disease in a Randomized Trial